MedTrace Logo

Reducing Lung Cancer-Related Anxiety (RELAX)

NCT02063828 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2021-03-05

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to compare the effects of music and different levels of device-guided breathing on anxiety and shortness of breath in lung cancer survivors.

Conditions

Interventions

DEVICE

Group A - Device guided breathing low dose

Group A: 15 minutes once a day, 5 days a week for 12 weeks.

DEVICE

Group B - Device guided breathing high dose

Group B - 15 minutes twice a day, 5 days a week for 12 weeks.

DEVICE

Group C - Usual Breathing Control Group

Group C - 15 minutes per day, 5 days a week for 12 weeks.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Suzanne C Danhauer, PhD · Wake Forest University Health Sciences

  • Glenn Lesser, MD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-30
Primary Completion
2019-12-23
Completion
2019-12-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02063828 on ClinicalTrials.gov